Personalized Post-Surgery Care Plan for Advanced Head and Neck Cancer
Part of Cancer clinical trials.
This study helps doctors create a personalized plan for follow-up treatment after surgery for advanced head and neck cancer. Researchers will use imaging scans and patient data to predict which patients need extra treatment and which ones can be monitored closely instead.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older
- Diagnosed with head and neck squamous cell carcinoma (a type of cancer in the mouth, throat, or voice box) confirmed by biopsy
- Cancer is locally advanced (large or spread to nearby areas) but has not spread to distant body parts
- Had surgery or other definitive treatment for the cancer
- Have imaging scans (MRI, CT, or PET-CT) taken before and after treatment
- Treated at Nanfang Hospital or partner hospitals between January 2017 and December 2025
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving radiation therapy after surgery, adjusted based on how the cancer responds, can improve outcomes for people with advanced head and neck cancer. It may help reduce side effects while keeping the treatment effective.
This study helps doctors plan surgery more individually for early-stage oral (mouth) squamous cell carcinoma. It focuses on using tumor features found during evaluation to guide surgical decisions, aiming to improve treatment accuracy.
This trial looks at whether patients with head and neck squamous cell carcinoma who had a good response to chemotherapy and immunotherapy before surgery can safely have less radiation after surgery. It aims to reduce side effects while keeping treatment effective.
This study collects blood and tumor tissue samples to analyze biological markers in patients with advanced head and neck squamous cell carcinoma before starting immunotherapy. The goal is to better understand how these markers relate to treatment response.
This trial tries a more personalized treatment approach for people with locally advanced head and neck cancers by testing their tumor and blood for cancer “genetic” clues. If you may be eligible, you would have fresh tumor (and possibly lymph node) biopsies at the start and again if the cancer returns, plus blood tests to guide research and future study options.
This study aims to find signs of head and neck cancer coming back early, using scans/tests after you’ve had radical treatment. If you’re at higher risk and HPV-negative, this may help doctors catch relapse sooner.
Hear when a new Deep Learning trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.